Hepion Pharmaceuticals, Inc. (CTRVP) Capital expenditures 2016–2024
Hepion Pharmaceuticals, Inc. (CTRVP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$14,304FY2024 · since FY2016: $6,603 → $14,304
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $14,304 | -12.4% |
| FY2023 | $16,336 | -87.5% |
| FY2022 | $130,405 | +48.2% |
| FY2021 | $87,983 | +70.9% |
| FY2020 | $51,469 | — |
| FY2017 | $14,709 | +122.8% |
| FY2016 | $6,603 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTRVP financial trends
CTRVP RevenueCTRVP Net incomeCTRVP Net marginCTRVP Gross profitCTRVP Gross marginCTRVP Operating incomeCTRVP Operating marginCTRVP Operating cash flowCTRVP Free cash flowCTRVP Return on equityCTRVP Stock buybacksCTRVP Dividends paidCTRVP Total assetsCTRVP Total liabilitiesCTRVP Shareholders’ equityCTRVP overview →